Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgery

Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgery

US Patent 12343320 · Granted Jul 1, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sotalol hydrochloride dosing2025
Method of escalating sotalol hydrochloride dosing2025
Ultra short acting anti-arrhythmic agents2025
Method of initiating or escalating dofetilide dose and formulations therefor2024
Ultra short acting anti-arrhythmic agents2023
Method of initiating and escalating sotalol hydrochloride dosing2023
Method of initiating or escalating dofetilide dose and formulations therefor2022
Method of converting atrial fibrillation to normal sinus rhythm and loading oral2022
Ultra short acting anti-arrhythmic agents2022
Ultra short acting anti-arrhythmic agents2020
Method of initiating and escalating sotalol hydrochloride dosing2019
Parenteral solutions containing metolazone2016